发明名称 |
Modulation of androgen receptor expression |
摘要 |
Certain embodiments are directed to compounds and compositions targeted to human androgen receptor (AR) for inhibiting androgen receptor levels in a cell, which can be useful for methods of treating cancer and inhibiting cancer cell growth or proliferation. |
申请公布号 |
US9175291(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US201314050574 |
申请日期 |
2013.10.10 |
申请人 |
ISIS Pharmaceuticals Inc. |
发明人 |
Macleod Robert A.;Kim Youngsoo;Zhou Tianyuan;Freier Susan M.;Monia Brett |
分类号 |
C12N15/11;C12N15/113;A61K31/7088;A61K31/4166 |
主分类号 |
C12N15/11 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound comprising a single-stranded modified oligonucleotide consisting of 16 linked nucleosides having a nucleobase sequence consisting of the sequence of SEQ ID NO: 35, or a pharmaceutically acceptable salt thereof, wherein the modified oligonucleotide comprises:
a gap segment consisting of 9 linked deoxynucleosides; a 5′ wing segment consisting of three linked nucleosides; and a 3′ wing segment consisting of four linked nucleosides;wherein the gap segment is positioned between the 5′ wing segment and the 3′ wing segment; the three linked nucleosides of the 5′ wing segment are each a constrained ethyl (cEt) sugar; the four linked nucleosides of the 3′ wing segment are a constrained ethyl (cEt) sugar, a constrained ethyl (cEt) sugar, a constrained ethyl (cEt) sugar, and a 2′-O-methoxyethyl sugar in the 5′ to 3′ direction; each internucleoside linkage is a phosphorothioate linkage; and each cytosine is a 5-methylcytosine. |
地址 |
Carlsbad CA US |